In addition to the classic biochemical features associated with IIH of hypercalcaemia, hypercalciuria and high levels of 1,25-dihydroxyvitamin D3, patients with SLC34A1 loss-of-function mutations exhibit hypophosphatemia [26]. Here, SLC34A1 is linked to Hypercalcemia.